secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001193125-24-019496
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics announces $250M public offering of 8.1M shares at $31.00 per share
--------------------------------------------------------------------------------

- Offering of 8,064,517 shares of Class A common stock at $31.00/share; gross proceeds ~$250.0M.
- Underwriters granted 30-day option to purchase up to 1,209,677 additional shares at same price less discounts.
- Underwriters include J.P. Morgan, Cowen, and Evercore as representatives; closing expected Feb 1, 2024.
- Use of proceeds not specified in the filing; likely general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524019496/0001193125-24-019496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524019496/d761446d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-019496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer